Literature DB >> 8731389

Ultrastructural immuno-localization of synthetic prion protein peptide antibodies in 87V murine scrapie.

M Jeffrey1, C M Goodsir, N Fowler, J Hope, M E Bruce, P A McBride.   

Abstract

Disease specific forms of a host encoded cell surface sialoglycoprotein called prion protein (PrP) accumulate during this incubation period of the transmissible spongiform encephalopathies. A 33-35 kDa disease specific form of PrP is partially resistant to protease digestion whereas the normal form of PrP can be completely digested. Proteinase K digestion of the murine disease specific form of PrP produces diverse forms of low molecular weight PrP, some of which are N-terminally truncated at amino acid residue 49 or 57 within the octapeptide repeat segment. Amyloid plaques are a pathological feature of many of the transmissible spongiform encephalopathies and are composed of PrP. Using synthetic peptide antibodies to the N-terminus of PrP (which is not present in truncated disease specific PrP) and antibodies to the protease resistant fraction of PrP we have immunostained plaques and pre-amyloid deposits in the brains of mice, experimentally infected with the 87V strain of scrapie, for examination by light and electron microscopy. Classical fibrillar amyloid deposits in plaques as well as pre-amyloid deposits were both immunostained by antibodies to the N-terminus of PrP and to the protease resistant core of the PrP molecule. This suggests that both N-terminal and core amino acid residues are present in disease specific PrP released from scrapie infected cells in vivo. The results also suggest that N-terminal truncation of PrP may not be essential for formation of amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731389     DOI: 10.1006/neur.1996.0014

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  9 in total

1.  Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.

Authors:  A Rangel; B Race; J Striebel; B Chesebro
Journal:  Neuropathol Appl Neurobiol       Date:  2013-04       Impact factor: 8.090

2.  Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.

Authors:  Brent Race; Martin Jeffrey; Gillian McGovern; David Dorward; Bruce Chesebro
Journal:  Prion       Date:  2017-07-31       Impact factor: 3.931

3.  Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.

Authors:  A C Gill; M A Ritchie; L G Hunt; S E Steane; K G Davies; S P Bocking; A G Rhie; A D Bennett; J Hope
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

4.  Stability of murine scrapie strain 87V after passage in sheep and comparison with the CH1641 ovine strain.

Authors:  Lorenzo González; Francesca Chianini; Nora Hunter; Scott Hamilton; Louise Gibbard; Stuart Martin; Mark P Dagleish; Sílvia Sisó; Samantha L Eaton; Angela Chong; Lynne Algar; Martin Jeffrey
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

5.  Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Authors:  Bruce Chesebro; Brent Race; Kimberly Meade-White; Rachel Lacasse; Richard Race; Mikael Klingeborn; James Striebel; David Dorward; Gillian McGovern; Martin Jeffrey
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

6.  Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy.

Authors:  Martin Jeffrey; Gillian McGovern; Emily V Chambers; Declan King; Lorenzo González; Jean C Manson; Bernardino Ghetti; Pedro Piccardo; Rona M Barron
Journal:  Brain Pathol       Date:  2011-07-25       Impact factor: 6.508

7.  The interpretation of disease phenotypes to identify TSE strains following murine bioassay: characterisation of classical scrapie.

Authors:  Katy E Beck; Christopher M Vickery; Richard Lockey; Thomas Holder; Leigh Thorne; Linda A Terry; Margaret Denyer; Paul Webb; Marion M Simmons; John Spiropoulos
Journal:  Vet Res       Date:  2012-11-01       Impact factor: 3.683

8.  Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs.

Authors:  Alexander Rouvinski; Sharon Karniely; Maria Kounin; Sanaa Moussa; Miri D Goldberg; Gabriela Warburg; Roman Lyakhovetsky; Dulce Papy-Garcia; Janine Kutzsche; Carsten Korth; George A Carlson; Susan F Godsave; Peter J Peters; Katarina Luhr; Krister Kristensson; Albert Taraboulos
Journal:  J Cell Biol       Date:  2014-02-03       Impact factor: 10.539

9.  Enhanced neuroinvasion by smaller, soluble prions.

Authors:  Cyrus Bett; Jessica Lawrence; Timothy D Kurt; Christina Orru; Patricia Aguilar-Calvo; Anthony E Kincaid; Witold K Surewicz; Byron Caughey; Chengbiao Wu; Christina J Sigurdson
Journal:  Acta Neuropathol Commun       Date:  2017-04-21       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.